Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,191 | -31,242 | -8,363 | -37,186 | -30,259 |
| Depreciation Amortization | 283 | 205 | 111 | 1,104 | 993 |
| Accounts receivable | N/A | -1,500 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -209 | 84 | 230 | -672 | -871 |
| Other Working Capital | -788 | -1,846 | 2,526 | -3,039 | -2,453 |
| Other Operating Activity | 21,025 | 21,882 | -1,122 | 4,332 | 4,099 |
| Operating Cash Flow | $-15,880 | $-12,418 | $-6,619 | $-35,461 | $-28,491 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 385 | 381 | 289 | 697 | -157 |
| Purchase Of Investment | -503 | -503 | N/A | -25,903 | -22,950 |
| Sale Of Investment | 4,817 | 4,311 | 4,314 | 57,477 | 49,053 |
| Investing Cash Flow | $4,699 | $4,189 | $4,603 | $32,272 | $25,946 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -746 |
| Debt Repayment | N/A | N/A | N/A | -2,307 | N/A |
| Common Stock Issued | 4 | 4 | N/A | 67 | 49 |
| Other Financing Activity | 8,753 | 8,771 | 0 | 0 | 0 |
| Financing Cash Flow | $8,757 | $8,775 | $N/A | $-2,240 | $-697 |
| Beginning Cash Position | 6,297 | 6,297 | 6,297 | 11,726 | 11,726 |
| End Cash Position | 3,872 | 6,842 | 4,280 | 6,297 | 8,484 |
| Net Cash Flow | $-2,425 | $546 | $-2,017 | $-5,429 | $-3,242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,880 | -12,418 | -6,619 | -35,461 | -28,491 |
| Capital Expenditure | -6 | N/A | N/A | -179 | -168 |
| Free Cash Flow | -15,886 | -12,418 | -6,619 | -35,640 | -28,659 |